AMORCYTE
Dead / Cancelled — Cancelled — Section 8 (as of 08 Jun 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76601855
- Registration number
- 3329938
- Mark type
- Stylized text
- Filed
- 12 Jul 2004
- Published for opposition
- 14 Jun 2005
- Registered
- 06 Nov 2007
- Attorney of record
- Susan Upton Douglass
Goods and services
- Class 005 — Pharmaceuticals: Biological tissue, namely, stem/progenitor cells for the treatment of various cardiovascular diseases
- Class 042 — Scientific and technological services: Research and development services regarding the use of stem/progenitor cells for the treatment of various cardiovascular diseases
Owner
- CALADRIUS BIOSCIENCES, INC., NEW YORK, NY, US
- NEOSTEM, INC., NEW YORK, NY, US
- AMORCYTE, INC., Allendale, NJ, US
- AMORCYTE, INC., HACKENSACK, NJ, US
- Progenitor Cell Therapy, LLC, Hackensack, NJ, US
- Progenitor Cell Therapy, LLC, Hackensack, NJ, US
Prosecution history
- 08 Jun 2018 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Nov 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Jul 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Mar 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Nov 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Nov 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Nov 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 20 Nov 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Nov 2013 — TEAS SECTION 8 & 15 RECEIVED
- 06 Nov 2007 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2007 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 30 Sept 2007 — ASSIGNED TO LIE
- 30 Aug 2007 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED